Shamburg News · 8-K filed Nov 16, 2026, 2:15 PM EST

Regenerex Pharma Appoints Rosenfield and Company PLLC as Independent Auditor

RGPX · REGENEREX PHARMA, INC.

  • Other
  • Materiality: high

On October 28, 2026, Regenerex Pharma, Inc.'s Board of Directors approved the appointment of Rosenfield and Company PLLC CPA of Corinth, Texas, as its independent registered public accounting firm, effective under an engagement letter dated October 26, 2026. The new auditor is preparing the company's past due Form 10-Q filings to bring it current with its reporting obligations. The filing was signed by Chairman and CEO Gregory P Pilant on November 16, 2026.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Item 4.01, accession 0001472375-26-000229.

Written from the filing by Shamburg Markets. Figures are as reported by the company.